BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 37199601)

  • 1. Impact of hepatitis C cure on risk of mortality and morbidity in people with HIV after antiretroviral therapy initiation.
    Chalouni M; Trickey A; Ingle SM; Sepuvelda MA; Gonzalez J; Rauch A; Crane HM; Gill MJ; Rebeiro PF; Rockstroh JK; Franco RA; Touloumi G; Neau D; Laguno M; Rappold M; Smit C; Sterne JAC; Wittkop L;
    AIDS; 2023 Aug; 37(10):1573-1581. PubMed ID: 37199601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of severe clinical events after sustained virological response following direct-acting antiviral therapy in HIV and hepatitis C virus coinfected participants.
    Chalouni M; Wittkop L; Bani-Sadr F; Lacombe K; Esterle L; Gilbert C; Miailhes P; Zucman D; Valantin MA; Brégigeon-Ronot S; Morlat P; Billaud E; Piroth L; Naqvi A; Sogni P; Salmon D;
    HIV Med; 2021 Oct; 22(9):791-804. PubMed ID: 34212476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sustained virological response after treatment with direct antiviral agents in individuals with HIV and hepatitis C co-infection.
    Lodi S; Klein M; Rauch A; Epstein R; Wittkop L; Logan R; Rentsch CT; Justice AC; Touloumi G; Berenguer J; Jarrin I; Egger M; Puoti M; D'Arminio Monforte A; Gill J; Salmon Ceron D; van Sighem A; Linas B; van der Valk M; Hernán MA;
    J Int AIDS Soc; 2022 Dec; 25(12):e26048. PubMed ID: 36562643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Higher sustained virological response rates at 12 weeks in HIV-HCV co-infection; a tertiary centre experience.
    Carvalho L; Pillai S; Daniels E; Sellers P; Whyte R; Eveson L; Foxton M; Nelson M
    J Infect; 2020 Feb; 80(2):232-254. PubMed ID: 31734343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human Immunodeficiency Virus (HIV) Infection Is Associated With Lower Risk of Hepatocellular Carcinoma After Sustained Virological Response to Direct-acting Antivirals in Hepatitis C Infected Patients With Advanced Fibrosis.
    Corma-Gómez A; Macías J; Lacalle-Remigio JR; Téllez F; Morano L; Rivero A; Serrano M; Ríos MJ; Vera-Méndez FJ; Alados JC; Real LM; Palacios R; Santos IL; Imatz A; Pineda JA;
    Clin Infect Dis; 2021 Oct; 73(7):e2109-e2116. PubMed ID: 32766891
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mortality in hepatitis C virus-cured vs. hepatitis C virus-uninfected people with HIV.
    Requena MB; Grabar S; Lanoy E; Pialoux G; Billaud E; Duvivier C; Merle P; Piroth L; Tattevin P; Salmon D; Weiss L; Costagliola D; Lacombe K
    AIDS; 2023 Jul; 37(8):1297-1306. PubMed ID: 37070541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HCV mono-infected and HIV/HCV co-infected individuals treated with direct-acting antivirals: to what extent do they differ?
    Bruno G; Saracino A; Scudeller L; Fabrizio C; Dell'Acqua R; Milano E; Milella M; Ladisa N; Monno L; Angarano G
    Int J Infect Dis; 2017 Sep; 62():64-71. PubMed ID: 28728927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV infection does not increase the risk of liver complications in hepatitis C virus-infected patient with advanced fibrosis, after sustained virological response with direct-acting antivirals.
    Corma-Gómez A; Morano L; Téllez F; Rivero-Juárez A; Real LM; Alados JC; Ríos-Villegas MJ; Vera-Méndez FJ; Muñoz RP; Geijo P; Macías J; Pineda JA;
    AIDS; 2019 Jun; 33(7):1167-1174. PubMed ID: 30845068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Creating a Longitudinal HCV Care Cascade for Persons With HIV/HCV Coinfection in Selected HIV Clinics Using Data to Care Methods.
    Brooks R; Wegener M; Speers S; Nichols L; Sideleau R; Valeriano T; Buchelli M; Villanueva M
    Health Promot Pract; 2023 Sep; 24(5):1039-1049. PubMed ID: 37439600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of control selection on sustained viral response rates in genotype 2/3 HCV mono-infected versus HIV/HCV co-infected patients.
    Nilsson J; Weiland O
    Scand J Infect Dis; 2010 Jul; 42(6-7):533-9. PubMed ID: 20214543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of hepatitis C in HCV mono-infected and in HIV-HCV co-infected patients: an open-labelled comparison study.
    Gonvers JJ; Heim MH; Cavassini M; Müllhaupt B; Genné D; Bernasconi E; Borovicka J; Cerny A; Chave JP; Chuard C; Dufour F; Dutoit V; Malinverni R; Monnat M; Negro F; Troilliet N; Oneta C
    Swiss Med Wkly; 2010; 140():w13055. PubMed ID: 20648398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in Response to Antiretroviral Therapy by Sex and Hepatitis C Infection Status.
    Marcus JL; Leyden WA; Chao CR; Xu L; Quesenberry CP; Tien PC; Klein DB; Towner WJ; Horberg MA; Silverberg MJ
    AIDS Patient Care STDS; 2015 Jul; 29(7):370-8. PubMed ID: 26061798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased mortality in HIV/HCV-coinfected compared to HCV-monoinfected patients in the DAA era due to non-liver-related death.
    Chalouni M; Pol S; Sogni P; Fontaine H; Lacombe K; Marc-Lacombe J; Esterle L; Dorival C; Bourlière M; Bani-Sadr F; de Ledinghen V; Zucman D; Larrey D; Salmon D; Carrat F; Wittkop L;
    J Hepatol; 2021 Jan; 74(1):37-47. PubMed ID: 32798585
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver Stiffness-Based Strategies Predict Absence of Variceal Bleeding in Cirrhotic Hepatitis C Virus-Infected Patients With and Without Human Immunodeficiency Virus Coinfection After Sustained Virological Response.
    Corma-Gómez A; Macías J; Morano L; Rivero A; Téllez F; Ríos MJ; Santos M; Serrano M; Palacios R; Merino D; Real LM; De Los Santos I; Vera-Méndez FJ; Galindo MJ; Pineda JA;
    Clin Infect Dis; 2021 Mar; 72(5):e96-e102. PubMed ID: 33211801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Hepatitis C Virus Cure on Depressive Symptoms in the Human Immunodeficiency Virus-Hepatitis C Virus Coinfected Population in Canada.
    Marathe G; Moodie EEM; Brouillette MJ; Lanièce Delaunay C; Cox J; Martel-Laferrière V; Gill J; Cooper C; Pick N; Vachon ML; Walmsley S; Klein MB;
    Clin Infect Dis; 2023 Feb; 76(3):e702-e709. PubMed ID: 35789253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune biomarker differences and changes comparing HCV mono-infected, HIV/HCV co-infected, and HCV spontaneously cleared patients.
    Kushner LE; Wendelboe AM; Lazzeroni LC; Chary A; Winters MA; Osinusi A; Kottilil S; Polis MA; Holodniy M
    PLoS One; 2013; 8(4):e60387. PubMed ID: 23593207
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluating the Cardiovascular Risk in an Aging Population of People With HIV: The Impact of Hepatitis C Virus Coinfection.
    Lang R; Humes E; Hogan B; Lee J; D'Agostino R; Massaro J; Kim A; Meigs JB; Borowsky L; He W; Lyass A; Cheng D; Kim HN; Klein MB; Cachay ER; Bosch RJ; Gill MJ; Silverberg MJ; Thorne JE; McGinnis K; Horberg MA; Sterling TR; Triant VA; Althoff KN
    J Am Heart Assoc; 2022 Oct; 11(19):e026473. PubMed ID: 36129038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors associated with non-AIDS-defining cancers and non HCV-liver related cancers in HIV/HCV-coinfected patients- ANRS-CO13 HEPAVIH cohort.
    Billa O; Chalouni M; Salmon D; Poizot-Martin I; Gilbert C; Katlama C; Neau D; Chas J; Morlat P; Lacombe K; Naqvi A; Barange K; Gervais A; Bouchaud O; Rosenthal E; Lascoux-Combe C; Garipuy D; Alric L; Dominguez S; Vittecoq D; Goujard C; Duvivier C; Aumaitre H; Miailhes P; Zucman D; Simon A; Lazaro E; Raffi F; Esterle L; Wittkop L; Bani-Sadr F;
    PLoS One; 2018; 13(12):e0208657. PubMed ID: 30562358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trends in hepatitis C virus coinfection and its cascade of care among adults living with HIV in Asia between 2010 and 2020.
    Ross J; Rupasinghe D; Avihingsanon A; Lee MP; Pujari S; Sharp G; Kumarasamy N; Khusuwan S; Khol V; Agus Somia IK; Pham TN; Kiertiburanakul S; Choi JY; Duy Do C; Sohn AH; Jiamsakul A;
    PLoS One; 2023; 18(6):e0287909. PubMed ID: 37379314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term outcome of liver complications in patients with chronic HBV/HCV co-infection after antiviral therapy: a real-world nationwide study on Taiwanese Chronic Hepatitis C Cohort (T-COACH).
    Yeh ML; Hung CH; Tseng KC; Lai HC; Chen CY; Kuo HT; Wang JH; Chen JJ; Lee PL; Chien RN; Yang CC; Lo GH; Tai CM; Lin CW; Kao JH; Liu CH; Yan SL; Bair MJ; Lin CY; Su WW; Chu CH; Chen CJ; Tung SY; Lo CC; Cheng PN; Chiu YC; Wang CC; Cheng JS; Tsai WL; Lin HC; Huang YH; Huang CF; Huang JF; Dai CY; Chuang WL; Tsai PC; Peng CY; Liu CJ; Yu ML
    Hepatol Int; 2021 Oct; 15(5):1109-1121. PubMed ID: 34365587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.